Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous magnesium sulfate versus succinylcholine for prevention of obturator nerve stimulation-related muscle contraction during transurethral bladder tumor resection
IRCT20130812014333N152Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of magnesium sulfate and succinylcholine in bladder cancer (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Muscular pain. Started Jun 2020; status: completed.
02
Drugs
magnesium sulfatesuccinylcholine
03
Conditions
bladder cancer
Beyond the preview
Go deeper on IRCT20130812014333N152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N152.